NLRP3 and metabolic syndrome: This is critical given the bidirectional relationship between oxidative stress and inflammation in MetS pathogenesis: ROS activate NF-κB and NLRP3 inflammasomes, driving cytokine production that further exacerbates insulin resistance and endothelial dysfunction [16].